Randomized trials of amifostine and radiotherapy: Effect on survival?
- 31 December 2004
- journal article
- research article
- Published by Elsevier in Seminars in Oncology
- Vol. 31, 62-66
- https://doi.org/10.1053/j.seminoncol.2004.12.015
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient dataInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Amifostine in clinical oncology: current use and future applicationsAnti-Cancer Drugs, 2002
- Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancerSeminars in Radiation Oncology, 2002
- Meta-analyses of randomised clinical trials in oncologyThe Lancet Oncology, 2001
- Has the outlook improved for amifostine as a clinical radioprotector?Radiotherapy and Oncology, 2000
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete RemissionNew England Journal of Medicine, 1999
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Meta-analysis of the literature or of individual patient data: is there a difference?The Lancet, 1993
- Publication Bias and Dissemination of Clinical ResearchJNCI Journal of the National Cancer Institute, 1989